Most often, mutations in APC with the resultant activation of β-catenin-dependent signaling and transcription initiate rapid cell proliferation, followed by mutations in the oncogene KRAS and subsequently in the tumor suppressor p53 that mediate and maintain cellular transformation and cancer growth [8,9,10]. The gene discussed is KRAS; the disease is cancer.